{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T01:55:27Z","timestamp":1772243727823,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.prp.2022.153957","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T21:22:56Z","timestamp":1653686576000},"page":"153957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["CRNDE inducing cisplatin resistance through SRSF1\/TIA1 signaling pathway in ovarian cancer"],"prefix":"10.1016","volume":"235","author":[{"given":"Jianfa","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suqin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2022.153957_bib1","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2022.153957_bib2","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2022.153957_bib3","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1038\/527S217a","article-title":"Ovarian cancer: beyond resistance","volume":"527","author":"David","year":"2015","journal-title":"Nature"},{"issue":"2016","key":"10.1016\/j.prp.2022.153957_bib4","first-page":"271","article-title":"Cancer treatment and survivorship statistics","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2022.153957_bib5","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"84","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2022.153957_bib6","article-title":"miR-194-5p inhibits SLC40A1 expression to induce cisplatin resistance in ovarian cancer","volume":"216","author":"Wu","year":"2020","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2022.153957_bib7","article-title":"Atovaquone at clinically relevant concentration overcomes chemoresistance in ovarian cancer via inhibiting mitochondrial respiration","volume":"224","author":"Guo","year":"2021","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2022.153957_bib8","doi-asserted-by":"crossref","first-page":"93502","DOI":"10.18632\/oncotarget.19548","article-title":"Nrf2 induces cisplatin resistance via suppressing the iron export related gene SLC40A1 in ovarian cancer cells","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2022.153957_bib9","first-page":"2299","article-title":"LncRNA CRNDE promotes hepatic carcinoma cell proliferation,migration and invasion by suppressing miR-384","volume":"6","author":"Chen","year":"2016","journal-title":"Am. J. Cancer Res"},{"key":"10.1016\/j.prp.2022.153957_bib10","first-page":"3992","article-title":"Expression of long non-coding RNA CRNDE in glioma and its correlation with tumor progression and patient survival","volume":"20","author":"Jing","year":"2016","journal-title":"Eur. Rev. Med Pharm. Sci."},{"key":"10.1016\/j.prp.2022.153957_bib11","doi-asserted-by":"crossref","DOI":"10.1007\/s13277-016-5440-0","article-title":"Highly expressed lncRNA CRNDE promotes cell proliferation through Wnt\/beta-catenin signaling in renal cell carcinoma","author":"Shao","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.prp.2022.153957_bib12","doi-asserted-by":"crossref","first-page":"72833","DOI":"10.18632\/oncotarget.12023","article-title":"Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway","volume":"7","author":"Shen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2022.153957_bib13","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3727\/096504017X14944585873668","article-title":"Long Noncoding RNA CRNDE\/PRC2 Participated in the Radiotherapy Resistance of Human Lung Adenocarcinoma Through Targeting p21 Expression","volume":"26","author":"Zhang","year":"2018","journal-title":"Oncol. Res"},{"key":"10.1016\/j.prp.2022.153957_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/OTT.S116178","article-title":"Long noncoding RNACRNDEfunctions as a competing endogenous RNA to promote metastasis and oxaliplatinresistanceby sponging miR-136 in colorectal cancer","volume":"10","author":"Gao","year":"2017","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.prp.2022.153957_bib15","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.bbrc.2019.08.113","article-title":"Nrf2 induced cisplatin resistance in ovarian cancer by promoting CD99 expression","volume":"518","author":"Wu","year":"2019","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.prp.2022.153957_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2019.104322","article-title":"Long non-coding RNA MIR205HG regulates KRT17 and tumor processes in cervical cancer via interaction with SRSF1","volume":"111","author":"Dong","year":"2019","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.prp.2022.153957_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112549","article-title":"Mitochondrial integration and ovarian cancer chemotherapy resistance","volume":"401","author":"Shen","year":"2021","journal-title":"Exp. Cell Res"},{"key":"10.1016\/j.prp.2022.153957_bib18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10495-020-01635-z","article-title":"RAB25 confers resistance to chemotherapy by altering mitochondrial apoptosis signaling in ovarian cancer cells","volume":"25","author":"Temel","year":"2020","journal-title":"Apoptosis"},{"key":"10.1016\/j.prp.2022.153957_bib19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ccell.2019.01.019","article-title":"Hacking the cancer genome: profiling therapeutically actionable long non-coding RNAs using CRISPR-Cas9 screening","volume":"35","author":"Esposito","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2022.153957_bib20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","article-title":"Long noncoding RNAs in cancer pathways","volume":"29","author":"Schmitt","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2022.153957_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.prp.2022.153957_bib22","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.3390\/ijms21228855","article-title":"LncRNAs in ovarian cancer progression, metastasis, and main pathways: ceRNA and alternative mechanisms","volume":"21","author":"Braga","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2022.153957_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111158","article-title":"Role of lncRNA LUCAT1 in cancer","volume":"134","author":"Xing","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.prp.2022.153957_bib24","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/cbf.3544","article-title":"LncRNA TUG1 facilitates proliferation, invasion and stemness of ovarian cancer cell via miR-186-5p\/ZEB1 axis","volume":"38","author":"Zhan","year":"2020","journal-title":"Cell Biochem Funct."},{"key":"10.1016\/j.prp.2022.153957_bib25","doi-asserted-by":"crossref","unstructured":"Chencheng Dai, Pengfei Xu, Siyu Liu, et al. Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells. Arch Gynecol Obstet. 303 (201) 1271\u20131281.","DOI":"10.1007\/s00404-020-05858-y"},{"key":"10.1016\/j.prp.2022.153957_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108728","article-title":"Atezolizumab and blockade of LncRNA PVT1 attenuate cisplatin resistant ovarian cancer cells progression synergistically via JAK2\/STAT3\/PD-L1 pathway","volume":"227","author":"Chen","year":"2021","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.prp.2022.153957_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.707424","article-title":"HOTTIP-miR-205-ZEB2 axis confers cisplatin resistance to ovarian cancer cells","volume":"9","author":"Dong","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.prp.2022.153957_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/wrna.1260","article-title":"The RNAissance family: SR proteins as multifaceted regulators of gene expression","volume":"6","author":"Howard","year":"2015","journal-title":"Wiley Inter. Rev. RNA"},{"key":"10.1016\/j.prp.2022.153957_bib29","doi-asserted-by":"crossref","first-page":"12043","DOI":"10.2147\/OTT.S267594","article-title":"MIR155HG knockdown inhibited the progression of cervical cancer by binding SRSF1","volume":"13","author":"Shen","year":"2020","journal-title":"Onco Targets Ther."},{"issue":"2021","key":"10.1016\/j.prp.2022.153957_bib30","article-title":"The GAUGAA motif is responsible for the binding between circSMARCA5 and SRSF1 and related downstream effects on glioblastoma multiforme cell migration and angiogenic potential","volume":"22","author":"Barbagallo","year":"1678","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2022.153957_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41420-021-00498-w","article-title":"SRSF1 promotes the inclusion of exon 3 of SRA1 and the invasion of hepatocellular carcinoma cells by interacting with exon 3 of SRA1pre-mRNA","volume":"7","author":"Lei","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.prp.2022.153957_bib32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bbrc.2020.10.061","article-title":"Long noncoding RNA LINC02580 suppresses the invasion-metastasis cascade in hepatocellular carcinoma by targeting SRSF1","volume":"533","author":"Xu","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2022.153957_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12967-021-02806-5","article-title":"CCL21 activation of the MALAT1\/SRSF1\/mTOR axis underpins the development of gastric carcinoma","volume":"19","author":"Fu","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prp.2022.153957_bib34","doi-asserted-by":"crossref","first-page":"6661520","DOI":"10.1155\/2021\/6661520","article-title":"lncRNA LINC01296 promotes oral squamous cell carcinoma development by binding with SRSF1","volume":"2021","author":"Zhang","year":"2021","journal-title":"Biomed. Res. Int."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822002011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822002011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:52:18Z","timestamp":1759733538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822002011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":34,"alternative-id":["S0344033822002011"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.153957","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRNDE inducing cisplatin resistance through SRSF1\/TIA1 signaling pathway in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.153957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153957"}}